1 Min Read
Jan 3 (Reuters) - Ligand Pharmaceuticals Inc:
* LIGAND EARNS $6 MILLION AS OMNIAB PARTNER OUT-LICENSES ANTIBODY PROJECTS
* SEES FY 2017 REVENUE ABOUT $140 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.